CARDIOVASCULAR SYSTEMS, INC.

(CSII)
  Bericht
Verzögert Nasdaq  -  27/05 22:00:00
16.08 USD   -0.31%
05.05.CARDIOVASCULAR SYSTEMS, INC. : Bewertung von SVB Leerink kaufen
MM
04.05.Earnings Flash (CSII) CARDIOVASCULAR SYSTEMS erzielt im 3. Quartal einen Umsatz von $56,2 Mio. gegenüber einer Straßenschätzung von $57,4 Mio.
MT
04.05.Cardiovascular Systems, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. März 2022
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über CARDIOVASCULAR SYSTEMS, INC.
11.05.TRANSCRIPT : Cardiovascular Systems, Inc. Presents at Bank of America 2022 Healthcare Conf..
05.05.CARDIOVASCULAR SYSTEMS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
04.05.TRANSCRIPT : Cardiovascular Systems, Inc., Q3 2022 Earnings Call, May 04, 2022
04.05.CARDIOVASCULAR SYSTEMS : Fiscal Q3 Earnings Snapshot
04.05.Earnings Flash (CSII) CARDIOVASCULAR SYSTEMS Posts Q3 Revenue $56.2M, vs. Street Est of..
04.05.Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
04.05.Cardiovascular Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
04.05.Cardiovascular Systems, Inc. Provides Earnings Guidance for the Fiscal Year 2022
13.04.Cardiovascular Systems, Inc. to Host Earnings Conference Call on May 4, 2022
30.03.Cardiovascular Systems Amends Loan Agreement to Extend Maturity Date by 1 Year
30.03.CARDIOVASCULAR SYSTEMS INC : Entry into a Material Definitive Agreement, Creation of a Dir..
30.03.Cardiovascular Systems, Inc. Enters into Second Amendment to Loan and Security Agreemen..
22.03.Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
16.03.Cardiovascular Systems, Inc. Announces First In-Human Experience With Company's Propel&..
16.03.Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Pr..
09.03.Cardiovascular Systems Says Enrollment Started in First In-Human Trial of Peripheral Ar..
09.03.Cardiovascular Systems, Inc. Announces First In-Human Experience With Peripheral Everol..
08.03.Cardiovascular Systems, Inc. Reports Earnings Results for the Second Quarter and Six Mo..
04.03.Cardiovascular Systems Inc. Names Jeffery Chambers Chief Medical Officer
04.03.Cardiovascular Systems, Inc. Appoints Jeffery W. Chambers, M.D., as Chief Medical Offic..
04.03.Cardiovascular Systems, Inc. Appoints Jeffery W. Chambers as Chief Medical Officer
03.03.CARDIOVASCULAR SYSTEMS INC : Change in Directors or Principal Officers (form 8-K)
03.03.Cardiovascular Systems, Inc. Announces Ryan Egeland Employment Would End as Chief Medic..
23.02.Cardiovascular Systems Partners With Innova Vascular To Develop Thrombectomy Devices
23.02.Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develo..
23.02.Cardiovascular Systems, Inc. Announces Partnership with Innova Vascular, Inc. to Develo..
03.02.CARDIOVASCULAR SYSTEMS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
03.02.TRANSCRIPT : Cardiovascular Systems, Inc., Q2 2022 Earnings Call, Feb 03, 2022
03.02.CARDIOVASCULAR : Fiscal Year 2022 Second Quarter Earnings Conference Call
03.02.CARDIOVASCULAR : REPORTS FISCAL 2022 SECOND QUARTER FINANCIAL RESULTS - Form 8-K
03.02.Cardiovascular Systems Reports Fiscal Q2 loss as Revenue Declines
03.02.NORTH AMERICAN MORNING BRIEFING : Tech Stocks Set -3-
03.02.CARDIOVASCULAR SYSTEMS : Fiscal Q2 Earnings Snapshot
03.02.Earnings Flash (CSII) CARDIOVASCULAR SYSTEMS Posts Q2 Revenue $59.1M, vs. Street Est of..
03.02.Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
03.02.Cardiovascular Systems, Inc. Provides Earnings Guidance for the Fiscal Year Ending June..
27.01.Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Confe..
20.01.Cardiovascular Systems, OrbusNeich Medical Get FDA Premarket Approval for Dilatation Ca..
20.01.Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Sco..
20.01.Cardiovascular Systems, Inc. Along with Orbusneich Medical Company Ltd, Announces FDA P..
13.01.Cardiovascular Systems Develops Intravascular Lithotripsy Technology for Coronary, Peri..
13.01.Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technol..
13.01.Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technol..
06.01.CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Qua..
2021CARDIOVASCULAR : Stifel 2021 California Bus Tour
2021Cardiovascular Systems, Inc. Initiates Voluntary Recall of WIRION Embolic Protection Sy..
2021Cardiovascular Systems Issues Recall of Unused WIRION Embolic Protection System Over Fi..
2021CARDIOVASCULAR : INITIATES VOLUNTARY RECALL OF WIRION® EMBOLIC PROTECTION SYSTEM - Form 8-..
2021CARDIOVASCULAR SYSTEMS INC : Other Events, Financial Statements and Exhibits (form 8-K)
2021Cardiovascular Systems, Inc. Initiates Voluntary Recall of WIRION® Embolic Protection S..
2021CARDIOVASCULAR SYSTEMS INC : Change in Directors or Principal Officers, Submission of Matt..
2021TRANSCRIPT : Cardiovascular Systems, Inc. - Shareholder/Analyst Call
2021CARDIOVASCULAR SYSTEMS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
2021TRANSCRIPT : Cardiovascular Systems, Inc., Q1 2022 Earnings Call, Nov 09, 2021
2021CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2022 FIRST QUARTER FINANCIAL RESULTS - Form..
2021Cardiovascular Systems Q1 Loss Widens, Revenue Slides, Company Sets Fiscal 2022 Outlook
2021Cardiovascular Systems, Inc. Fiscal Year 2022 First Quarter Earnings Conference Call
2021CARDIOVASCULAR SYSTEMS : Fiscal Q1 Earnings Snapshot
2021Cardiovascular Systems, Inc. Reports Fiscal 2022 First Quarter Financial Results
2021Earnings Flash (CSII) CARDIOVASCULAR SYSTEMS Reports Q1 Revenue $58.4M, vs. Street Est ..
2021Cardiovascular Systems, Inc. Provides Earnings Guidance for the Fiscal Year Ending June..
2021Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolim..
2021Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolim..
2021Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Confe..
2021CARDIOVASCULAR SYSTEMS, INC. : to Webcast Fiscal 2022 First-Quarter Earnings Conference Ca..
2021IMPEDIMED : Chair to Retire at End of Annual General Meeting
2021CARDIOVASCULAR : Says First Patient Successfully Treated with ViperCross Peripheral Suppor..
2021CARDIOVASCULAR SYSTEMS, INC. : Announces First Patient Treated with ViperCross™ Peri..
2021Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross Peripheral..
2021CARDIOVASCULAR : 2021 Stockholder Letter
2021CARDIOVASCULAR : Says Negative Impact of COVID-19 on Its Operations Might Result in Lower ..
2021CARDIOVASCULAR SYSTEMS INC : Regulation FD Disclosure (form 8-K)
2021CARDIOVASCULAR : First Patients in Canada Treated With Cardiovascular Systems' Orbital Ath..
2021CARDIOVASCULAR : First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamon..
2021Cardiovascular Systems, Inc. Announces First Patients in Canada Have Been Treated with ..
1  2  3  4  5  6  7  8  9Weiter
Anstehende Termine für CARDIOVASCULAR SYSTEMS, INC.